Sign in

    Stacy Price, M.S.

    Chief Technology and Manufacturing Officer at Invivyd Inc
    Since March 27, 2023
    Age
    55 years
    Education
    Holds an M.S. in Biochemical Engineering and a B.S. in Chemical Engineering from Tufts University.
    Tenure
    Started tenure at Invivyd, Inc. as Chief Technology and Manufacturing Officer on March 27, 2023, bringing over 25 years of experience in biotechnology operations management.

    Also at Invivyd Inc

    About

    Stacy Price, M.S. is a seasoned executive with over 25 years of experience in biotechnology operations management, having held high‐level technical roles at companies such as Akouos, Inc. and Ziopharm Oncology, Inc..

    She currently serves as the Chief Technology and Manufacturing Officer at Invivyd, Inc., joining on March 27, 2023, and has been instrumental in shaping technical and manufacturing strategies at the company.

    Her career is marked by a commitment to operational excellence and innovation, underpinned by her strong educational background in biochemical and chemical engineering. This blend of technical expertise and extensive leadership experience enables her to address complex challenges in the biotechnology industry effectively.

    Past Roles

    OrganizationRoleDate RangeDetails
    Akouos, Inc. Chief Technical Officer November 2021 to March 2023 Established technical operations strategy for multiple adeno-associated virus combination gene therapy programs; contributed to IND application
    Ziopharm Oncology, Inc. Senior Vice President of Technical Operations February 2020 to September 2021 Oversaw CMC strategy and facilities construction for a research and manufacturing site for cell and combination gene therapy products
    Ziopharm Oncology, Inc. Vice President of Technical Operations May 2017 to February 2020 Oversaw the development and delivery of CMC strategy and facilities construction for cell and combination gene therapy products
    Various Multiple manufacturing and operational roles N/A Held roles of increasing responsibility across the pharmaceutical and biotechnology industry

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base SalaryN/A N/A No specific details provided for 2024
    Equity CompensationN/A N/A No specific details provided for 2024
    Other BenefitsN/A N/A No specific details provided for 2024
    Expense ReimbursementN/A N/A No specific details provided for 2024

    Performance Compensation

    Data from  FY 2024

    No information available on performance compensation for 2024